Advertisement
New Zealand markets closed

  • NZX 50

    12,823.89
    +55.35 (+0.43%)
     

  • NZD/USD

    0.6063
    +0.0003 (+0.05%)
     

  • NZD/EUR

    0.5590
    +0.0000 (+0.01%)
     

  • ALL ORDS

    8,534.20
    -89.90 (-1.04%)
     

  • ASX 200

    8,266.00
    -89.90 (-1.08%)
     

  • OIL

    70.94
    +0.27 (+0.38%)
     

  • GOLD

    2,724.70
    +17.20 (+0.64%)
     

  • NASDAQ

    20,190.42
    +16.38 (+0.08%)
     

  • FTSE

    8,385.13
    +56.06 (+0.67%)
     

  • Dow Jones

    43,239.05
    +161.35 (+0.37%)
     

  • DAX

    19,583.39
    +150.58 (+0.77%)
     

  • Hang Seng

    20,229.94
    +150.84 (+0.75%)
     

  • NIKKEI 225

    38,921.18
    +9.99 (+0.03%)
     

  • NZD/JPY

    90.8660
    -0.0940 (-0.10%)
     

West Pharmaceutical: Q2 Earnings Snapshot

Associated Press Finance
·1-min read

EXTON, Pa. (AP) — EXTON, Pa. (AP) — West Pharmaceutical Services Inc. (WST) on Thursday reported second-quarter net income of $111.3 million.

On a per-share basis, the Exton, Pennsylvania-based company said it had profit of $1.51. Earnings, adjusted for amortization costs, were $1.52 per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.77 per share.

The medical device company posted revenue of $702.1 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $737.7 million.

West Pharmaceutical expects full-year earnings in the range of $6.35 to $6.65 per share, with revenue in the range of $2.87 billion to $2.9 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WST at https://www.zacks.com/ap/WST